A Randomized, Double‐Blind, Placebo‐Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss

OBJECTIVE: This study aims to assess the efficacy and safety of Gelesis100, a novel, nonsystemic, superabsorbent hydrogel to treat overweight or obesity. METHODS: The Gelesis Loss Of Weight (GLOW) study was a 24‐week, multicenter, randomized, double‐blind, placebo‐controlled study in patients with B...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Obesity (Silver Spring)
Autors principals: Greenway, Frank L., Aronne, Louis J., Raben, Anne, Astrup, Arne, Apovian, Caroline M., Hill, James O., Kaplan, Lee M., Fujioka, Ken, Matejkova, Erika, Svacina, Stepan, Luzi, Livio, Gnessi, Lucio, Navas‐Carretero, Santiago, Alfredo Martinez, J., Still, Christopher D., Sannino, Alessandro, Saponaro, Cosimo, Demitri, Christian, Urban, Lorien E., Leider, Harry, Chiquette, Elaine, Ron, Eyal S., Zohar, Yishai, Heshmati, Hassan M.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587502/
https://ncbi.nlm.nih.gov/pubmed/30421844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.22347
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars